timosan depot 1 mg/g øjengel, enkeltdosisbeholder
santen oy - timololmaleat - øjengel, enkeltdosisbeholder - 1 mg/g
timosan depot 1 mg/g øjengel
santen oy - timololmaleat - øjengel - 1 mg/g
timosan depot 1 mg/g øjengel
2care4 aps - timololmaleat - øjengel - 1 mg/g
timosan depot 1 mg/g øjengel
orifarm a/s - timololmaleat - øjengel - 1 mg/g
cortiment 9 mg depottabletter
ferring lægemidler a/s - budesonid - depottabletter - 9 mg
timosan depot 1 mg/g øjengel
paranova danmark a/s - timololmaleat - øjengel - 1 mg/g
bronchosan orale dråber, opløsning
bioforce danmark as - lakridsrod, timian ekstrakt, vedbend, urt, ekstrakt - orale dråber, opløsning
mucopret filmovertrukne tabletter
bionorica se - primularod, ekstrakt, timian ekstrakt - filmovertrukne tabletter
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - alle andre terapeutiske produkter - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - multipelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.